SEC Form 4 · accession 0001479791-18-000018
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Feb 21, 2018 | S | 1,000 | $0.12 | D | 25,295,764 | D | |
| INVO Bioscience Common Stock | Mar 5, 2018 | S | 12,642 | $0.19 | D | 25,283,122 | D |
Table II — derivative securities
Remarks
Today I recalculated the amount of securities I owned after selling all the 500,000 shares granted on 12/08/2017 following a form 144. During the last 3 months, I sold and reported 1,000,000 shares. I started with 26,283,122 shares. After a thorough review, I found a discrepancy of 1,000 shares corresponding to a sale at $0.12 executed on 02/21/2018 and I reported it today. The error came from the sale of 13,400 shares which I reported as 12,400 shares. I apologize for this error that I am unable to explain as I always performed several verifications before sending each report. The number of traded shares also came from a Form-4 that I filled before reporting to the SEC with an information provided by my broker.